Your browser doesn't support javascript.
loading
High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials.
Sheng, Xiao-Yan; An, Hui-Jie; He, Yong-Yang; Ye, Yong-Feng; Zhao, Jia-Lan; Li, Sai.
Afiliación
  • Sheng XY; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • An HJ; General Hospital of Southern Theatre Command, PLA, Guangzhou, China.
  • He YY; Shenzhen Children's Hospital, Shenzhen, China.
  • Ye YF; The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, China.
  • Zhao JL; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
  • Li S; Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
J Clin Pharm Ther ; 47(8): 1112-1121, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35396752
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Guideline / Qualitative_research / Systematic_reviews Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome Coronario Agudo / Intervención Coronaria Percutánea Tipo de estudio: Clinical_trials / Guideline / Qualitative_research / Systematic_reviews Límite: Humans Idioma: En Revista: J Clin Pharm Ther Asunto de la revista: FARMACIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China